Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isoeugenol is a naturally occurring phenylpropanoid compound found in the essential oils of various plants such as ylang-ylang. It is an isomer of eugenol and functionally related to guaiacol. Isoeugenol has been widely used as a fragrance ingredient in perfumes and other consumer products, but its use has been restricted due to its strong potential as a dermatologic sensitizer and allergen[1][2]. It also plays a role in the mold-inhibiting effect of smoke on meats and cheeses[3]. In medicine, it is approved by the FDA for use within allergenic epicutaneous patch tests to aid in diagnosing allergic contact dermatitis (ACD) in individuals aged six years or older[2]. Isoeugenol acts as an anesthetic agent for fish, though its precise mechanism of action remains undetermined; it may decrease nerve activity at low concentrations[4]. Structurally related compounds include eugenol, safrole, estragole, methyleugenol, and isosafrole[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isoeugenol.